Helius Medical Technologies (NASDAQ:HSDT) projects Q4 revenue to be in the range of $275,000 and $285,000 vs consensus of $279K, a sequential increase of ~40%, reflecting the U.S. commercial launch of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results